Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-11-12 4:40 pm Purchase | 13G | THERAPEUTICSMD INC TXMD | Clearline Capital LP | 636,622 5.520% | 636,622 (New Position) | View |
2023-11-17 09:28 am Purchase | 13D | THERAPEUTICSMD INC TXMD | Rubric Capital Management LP | 2,946,908 25.730% | 877,192 (+42.38%) | View |
2023-06-30 08:29 am Purchase | 13D | THERAPEUTICSMD INC TXMD | Rubric Capital Management LP | 2,069,716 19.570% | 347,763 (+20.20%) | View |
2022-08-30 09:09 am Unchanged | 13D | THERAPEUTICSMD INC TXMD | Rubric Capital Management LP | 1,721,953 18.270% | 0 (Unchanged) | View |
2022-08-08 4:42 pm Purchase | 13D | THERAPEUTICSMD INC TXMD | Rubric Capital Management LP | 1,721,953 18.270% | 1,721,953 (New Position) | View |
2022-07-08 4:52 pm Purchase | 13G | THERAPEUTICSMD INC TXMD | BlackRock Inc. BLK | 122,138 1.400% | 122,138 (New Position) | View |
2022-06-03 4:39 pm Purchase | 13G | THERAPEUTICSMD INC TXMD | Beryl Capital Management LLC | 126,229 1.500% | 126,229 (New Position) | View |
2022-03-23 4:17 pm Purchase | 13D | THERAPEUTICSMD INC TXMD | SMITH ROBERT J | 23,103,292 5.380% | 13,164,584 (+132.46%) | View |
2022-02-14 2:34 pm Sale | 13G | THERAPEUTICSMD INC TXMD | PRICE T ROWE ASSOCIATES INC | 649,807 0.100% | -18,219,405 (-96.56%) | View |
2022-01-31 5:49 pm Purchase | 13G | THERAPEUTICSMD INC TXMD | BlackRock Inc. BLK | 24,894,812 5.900% | 3,475,539 (+16.23%) | View |
2021-07-07 2:02 pm Purchase | 13G | THERAPEUTICSMD INC TXMD | Flynn James E | 20,662,810 4.900% | 20,662,810 (New Position) | View |
2021-02-16 12:23 pm Sale | 13G | THERAPEUTICSMD INC TXMD | PRICE T ROWE ASSOCIATES INC | 18,869,212 6.200% | -370,333 (-1.92%) | View |
2021-02-10 11:57 am Sale | 13G | THERAPEUTICSMD INC TXMD | VANGUARD GROUP INC | 13,165,644 4.390% | -3,429,581 (-20.67%) | View |
2021-02-08 10:33 am Sale | 13G | THERAPEUTICSMD INC TXMD | FMR LLC | 14,116,461 4.709% | -3,561,014 (-20.14%) | View |
2021-02-01 08:23 am Purchase | 13G | THERAPEUTICSMD INC TXMD | BlackRock Inc. BLK | 21,419,273 7.100% | 3,160,130 (+17.31%) | View |
2020-12-09 11:54 am Sale | 13G | THERAPEUTICSMD INC TXMD | JPMORGAN CHASE & CO JPM | 13,079,428 4.300% | -6,638,618 (-33.67%) | View |
2020-02-14 1:30 pm Sale | 13G | THERAPEUTICSMD INC TXMD | PRICE T ROWE ASSOCIATES INC | 19,239,545 7.000% | -2,282,800 (-10.61%) | View |
2020-02-12 11:13 am Purchase | 13G | THERAPEUTICSMD INC TXMD | VANGUARD GROUP INC | 16,595,225 6.110% | 3,299,729 (+24.82%) | View |
2020-02-07 11:32 am Sale | 13G | THERAPEUTICSMD INC TXMD | FMR LLC | 17,677,475 6.518% | -410,866 (-2.27%) | View |
2020-02-06 09:10 am Purchase | 13G | THERAPEUTICSMD INC TXMD | BlackRock Inc. BLK | 18,259,143 6.700% | 1,571,580 (+9.42%) | View |